Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Resources>Webcasts

  Webcasts

Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.

Testing Drug-Induced Inhibition of hERG: How Voltage and Inactivation Makes a Difference
Harry Witchel, Senior Lecturer in Physiology, Brighton and Sussex Medical School, University of Sussex, speaking at ADMET Europe 2009

From Batch to Flow: New Methods in Microwave-assisted Synthesis
Mark Bagley, Senior Lecturer, Cardiff University, speaking at Advances in Synthetic Chemistry 2009

Antibody Microarray for Foodborne Pathogen Detection using NanoDetector
Nitsara Karoonuthaisiri, Head of Microarray Laboratory, National Center for Genetic Engineering and Biotechnology, speaking at Microarray World Congress 2009

MS Binding Assays - A New Concept for Drug Screening
Klaus Wanner, Full Professor, Ludwig- Maximilians-University Munich, speaking at Screening Europe 2009

Pharmacological Characterization of GPRC6A – A 7TM Receptor Activated by L-a-Amino Acids and Positively Modulated by Divalent Cations
Petrine Wellendorph, Associate Professor, University of Copenhagen, speaking at Screening Europe 2009

vHTS versus HTS in Ion Channel Research
Stefan Tasler, Senior Scientist, 4SC, speaking at Screening Europe 2009

In silico Chemogenomics with Support Vector Machines
Jean-Phillippe Vert, Ecole des Mines de Paris, speaking at MedChem Europe 2009

Kinase Inhibitors with Tailored Binding Kinetics by Fragment-Based Design
Peter Sennhenn, Head of Medicinal Chemistry, Proteros fragments GmbH, speaking at MedChem Europe 2009

Development of Proteomics Methods for Profiling Cytochrome P450s
Chris Sutton, Head of the ICT Proteomics and Mass Spectrometry Facility, Bradford University, speaking at ADMET Europe 2009

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 155
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!